There is a high risk for falls among older adults with masked hypertension, defined as a higher blood pressure at home vs in office.

Patients with advanced cardiometabolic disease face a higher risk for major adverse cardiac events after metabolic bariatric surgery.

GLP-1 receptor agonists are linked to lower rates of all-cause mortality and ischemic stroke in adults with obesity and elevated C-reactive protein.

Researchers evaluated the impact of menopausal hormone therapy on cardiovascular disease risk among women in midlife experiencing vasomotor symptoms.

Transgender and gender diverse veterans face a higher risk for incident heart failure than cisgender women, but a lower risk than cisgender men.

Alcohol-related cirrhosis complicated by heart failure in Western Europe is associated with the highest disability burden.

A new generic hormone therapy patch used to treat symptoms of menopause will be available following recent FDA approval.

Patients with heavily calcified coronary lesions treated with a 2-Hz intravascular lithotripsy catheter have low MACE rates at 1 year.

Arab American adults experience a high prevalence of atherosclerotic cardiovascular disease and related cardiometabolic risk factors.

Transgender and gender diverse patients face a significantly higher risk for cardiovascular diseases compared with cisgender individuals.

For patients with AF and prior intracranial bleeding, DOACs are associated with a reduced risk for IS and death, without an increased risk for intracranial bleeding.

GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.